T J van Vroonhoven, J van Zijl, H Muller. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Acenocoumarol/administration & dosageAcenocoumarol/therapeutic useAdministration, OralAdultAgedBlood Coagulation TestsClinical Trials as TopicDrug EvaluationFibrinogenHeparin/administration & dosageHeparin/therapeutic useHumansInjections, SubcutaneousIodine RadioisotopesMiddle AgedPostoperative Complications/prevention & controlPulmonary Embolism/etiologyPulmonary Embolism/prevention & controlSurgical Procedures, Operative/adverse effectsThrombophlebitis/etiologyThrombophlebitis/prevention & control
Substances: See more » Iodine RadioisotopesFibrinogenHeparinAcenocoumarol
Year: 1974 PMID: 4131031 DOI: 10.1016/s0140-6736(74)93147-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321